GRCE Stock Analysis: Buy, Sell, or Hold?
GRCE - Grace Therapeutics, Inc. Common Stock
$2.45
-0.05 (-2.00%)
▼
5d:
+5.15%
30d:
+3.81%
90d:
-36.69%
BUY
MODERATE Confidence
Analysis Updated: Jun 3, 2026 12:00 AM ET
Earnings: Jun 22, 2026
17d
Get Alerted When GRCE Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: GRCE shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: GRCE shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: GRCE is currently trading at $2.45, which is considered extended relative to its 30-day fair value range of $2.16 to $2.44.
Technical Outlook: Technically, GRCE is in a downtrend. Immediate support is located at $2.11, while resistance sits at $2.71.
Market Sentiment: GRCE has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $5.93 (+141.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, GRCE is in a downtrend. Immediate support is located at $2.11, while resistance sits at $2.71.
Market Sentiment: GRCE has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $5.93 (+141.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$2.16 -
$2.44
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
63.2%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 141.9% below Wall St target ($5.93)
Trading Range Analysis
30-Day Trading Range
$2.16 -
$2.44
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$2.11
Resistance Level
$2.71
Current Trend
Downtrend
Technical data as of
Jun 3, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-2.58
Wall Street Target
$5.93
(+141.9%)
Share & Embed Analysis
Last updated: June 03, 2026 10:06 PM ET
Data refreshes hourly during market hours. Next update: 11:06 PM
Data refreshes hourly during market hours. Next update: 11:06 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is GRCE showing a specific setup today?
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$55 | 66 BUY |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$833 | 58 HOLD |
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$548 | 53 HOLD |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$79 | 55 HOLD |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$52 | 53 HOLD |